As of June 2024 Alpine Immune Sciences has a market cap of $4.45 Billion. This makes Alpine Immune Sciences the world's 2839th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $4.45 B | 302.47% |
2023 | $1.10 B | 228.13% |
2022 | $0.33 B | -19.3% |
2021 | $0.41 B | 39.43% |
2020 | $0.29 B | 320.19% |
2019 | $71.37 M | 40% |
2018 | $50.98 M | -67.21% |
2017 | $0.15 B | 346.54% |
2016 | $34.81 M | -70.91% |
2015 | $0.11 B |
On Jun 1st, 2024 the market cap of Alpine Immune Sciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | $0.60 B | -86.40% | ๐บ๐ธ USA |